ArticleInternational journal of surgery (London, England)2026
Incidence and risk factors for symptomatic gallstone disease after gastrectomy for gastric cancer: a nationwide population-based study.
Article in International journal of surgery (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGallstone formation is a potential long-term complication of gastrectomies. However, data on symptomatic gallstone disease after gastrectomy for gastric cancer are limited. This nationwide population-based study aimed to determine the incidence and risk factors of symptomatic gallstone disease requiring invasive intervention.
methodThis nationwide cohort study was based on claims data from the Korean National Health Insurance Service Database. The study included 90 456 patients who underwent gastrectomy for gastric cancer between 2007 and 2020 after excluding individuals with prior gallbladder disease, liver dysfunction, or ursodeoxycholic acid use. The primary outcome was symptomatic gallstone disease that required invasive intervention (cholecystectomy or endoscopic/percutaneous biliary procedures). Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using the Cox proportional hazards analysis.
resultsDuring a mean follow-up of 7.5 years, 6465 patients (7.1%) developed symptomatic gallstone disease requiring invasive intervention, with 5-year and 10-year cumulative incidences of 4.9% and 8.9%, respectively. Independent risk factors included age 60-79 years (HR 1.49, 95% CI 1.25-1.78) and ≥ 80 years (HR 2.10, 95% CI 1.69-2.61), body mass index ≥ 25 kg/m2 (HR 1.25, 95% CI 1.19-1.32), hypertension (HR 1.10, 95% CI 1.04-1.16), diabetes mellitus (HR 1.10, 95% CI 1.04-1.17), Charlson Comorbidity Index ≥ 6 (HR 1.32, 95% CI 1.23-1.43), total gastrectomy (HR 1.80, 95% CI 1.70-1.90), and adjuvant chemotherapy (HR 2.11, 95% CI 1.98-2.24). Female sex (HR 0.76, 95% CI 0.71-0.82), pylorus-preserving gastrectomy (HR 0.47, 95% CI 0.33-0.67), and laparoscopic surgery (HR 0.85, 95% CI 0.81-0.90) were protective.
conclusionSymptomatic gallstone disease requiring invasive intervention occurred in 7.1% of the patients after gastrectomy for gastric cancer, representing a substantial increase compared to the general population. Pylorus-preserving gastrectomy and laparoscopic surgery were associated with a lower risk, suggesting that the surgical approach may influence the long-term gallstone risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.